The UCSF community recognized the stellar efforts of a student as well as faculty and staff members at the annual Martin Luther King, Jr. Awards on Jan. 25.
January 21, 2011
December 13, 2010
UCSF physicians are combating a devastating side effect of chemotherapy with an innovative new program -- “Hair to Stay” -- to evaluate devices that could reduce scalp hair loss in breast cancer patients.
November 29, 2010
In a new UCSF study of more than 2 million mammogram screenings performed on nearly 700,000 women in the United States, scientists for the first time show a direct link between reduced hormone therapy and declines in ductal carcinoma in situ (DCIS) as well as invasive breast cancer.
November 09, 2010
Smoking in women with breast cancer increases breast cancer deaths and deaths overall, according to preliminary research results presented by UCSF epidemiologist Dejana Braithwaite, PhD, at a meeting of the American Association for Cancer Research.
September 24, 2010
Basic physical limitations following breast cancer treatment can have far-reaching consequences that substantially affect how long a patient lives.
September 21, 2010
Cancer and infertility can be a double blow. Many women become infertile following cancer treatment. And because more women are living longer thanks to modern chemotherapy and radiation treatment, more are later discovering that they cannot bear children.
June 07, 2010
A single dose of radiation administered during surgery is as effective for patients with early forms of breast cancer as standard radiation therapy that can take as long as six weeks, according to new research findings.
June 07, 2010
Fellows, residents and students from all four professional schools shared their research recently during the First Annual Inter-School Research Festival at UCSF.
April 28, 2010
For the first time, scientists have discovered a way to predict whether women with ductal carcinoma in situ (DCIS) – the most common form of non-invasive breast cancer – are at risk of developing more invasive tumors in later years.
March 18, 2010
Taking an innovative path toward personalized medicine, scientists for the first time will be able to eliminate – at an early point in a clinical trial — experimental drugs that show poor efficacy, dramatically shortening the time it takes to get the right medication to the right patient with breast cancer.